Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients?

Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000409?ecd=bdc_podcast_libsyn_mscpedu